(1)
Treatment Outcomes of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-Transporter-2 Inhibitors in Diabetes Mellitus With Poor Glycemic Control. J. Medicine 2024, 25 (2), 107-114. https://doi.org/10.3329/jom.v25i2.74306.